Limited genetic changes in the Sabin 1 strain of poliovirus occurring in the central nervous system of monkeys

Journal of General Virology

Volumn 77, Issue 2, 1996, Pages 273-280

  Lu, Zhengbin ^a   Rezapkin, Gennady V ^a   Douthitt, Monica P ^a   Ran, Yuxin ^a   Asher, David M ^a   Levenbook, Inessa S ^a   Chumakov, Konstantin M ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLYADENYLIC ACID; RESTRICTION ENDONUCLEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; GENE MUTATION; HUMAN; HUMAN CELL; INOCULATION; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POLIOMYELITIS VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHESUS MONKEY; SPINAL CORD INFECTION; VIRAL GENETICS; VIRUS ATTENUATION; VIRUS REPLICATION;

ANIMALIA; MACACA MULATTA; POLIOVIRUS;

EID: 0030044747     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-2-273     Document Type: Article

References (28)

1. BENYESH-MELNICK, M. & MELNICK, J L (1959). The use of in vitro markers and monkey neurovirulence tests to follow genetic changes in attenuated poliovirus multiplying in the human alimentary tract. Pan-American Health Organization, Scientific Publication no. 44, pp. 179-198, Washington: Pan-American Health Organization.
2. BOUCHARD, M. J , LAM. D.-H. & RACANIELLO, V R. (1995) Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. Journal of Virology 69, 4972-4978.
3. CHRISTODOULOU, C., COLBERE-GARAPIN, F., MACADAM, A., TAFFS, L. F., MARSDEN, S., MINOR, P. & HORAUD, F. (1990). Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. Journal of Virology 64, 4922-1929.
4. CHUMAKOV, K. M., POWERS, L. B., NOONAN, K. E., RONINSON, I. B. & LEVENBOOK, I. S. (1991). Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proceedings of the National Academy of Sciences, USA 88, 199-203.
5. CHUMAKOV, K. M., NORWOOD, L. P., PARKER, M. L., DRAGUNSKY, E. M., RAN, Y. & LEVENBOOK, I. S. (1992) RNA sequence vanants in live poliovirus vaccine and their relation to neurovirulence. Journal of Virology 66, 966-970.
6. CHUMAKOV, K., NORWOOD, L., PARKER, M., DRAGUNSKY, E., TAFFS, R., RAN. Y , RIDGE, J. & LEVENBOOK, 1. (1993). Assessment of the Viral RNA sequence heterogeneity for control of OPV neurovirulence. Developments in Biological Standardization 78, 79-89
7. CHUMAKOV, K. M . DRAGUNSKY, E. M., NORWOOD, L. P., DOUTHITT, M. P., RAN. Y , TAFFS, R. E., RIDGE, J. & LEVENBOOK, I. S. (1994). Consistent selection of mutations in the 5′-untranslated region of oral poliovirus vaccine upon passaging in vitro. Journal of Medical Virology 42, 79-85
8. DOMINGO, E., MARTINEZ-SALAS. E., SOBRINO, F., DE LATORRE, J. C., PORTILA, A , ORTÍN. J., LOPEZ-GOLINDEZ, C., PEREZ-BRENA, P., VILLA-NUEVA, N , NAJERA, R., VANDEPOL, S., STEINHAUER, D , DEPOLO, N & HOLLAND, J. J. (1985). The quasispecies (extremely heterogenous) nature of viral RNA genome populations: biological relevance - a review Gene 40, 1-8.
9. HOLLAND, J., SPINDLER, K., HORODYSKI, F , GRABAU, E., NICHOL, S. & VANDEPOL, S. (1982) Rapid evolution of RNA genomes. Science 215, 1576-1585.
10. KAWAMURA, N., KOHARA, M., ABE, S , KOMATSU, T , TAGO, K., ARITA, M & NOMOTO, A. (1989). Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. Journal of Virology 63, 1302-1309
11. LU, Z. DOUTHITT, M. P., TAFFS, R. E., RAN, Y., NORWOOD, L. P. & CHUMAKOV, K. M. (1993). Quantitative aspects of the mutant analysis by PCR and restriction enzyme cleavage (MAPREC). PCR Methods and Applications 3, 176-180.
12. MACADAM, A. J., POLLARD, S. R., FERGUSON, G., DUNN, G., SKUCE, R., ALMOND, J. W. & MINOR, P. D. (1991). The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology 181, 451-458.
13. MACADAM, A. J., STONE, D. M., ALMOND, J. W. & MINOR, P. D. (1994). The 5′ noncoding region and virulence of poliovirus vaccine strains. Trends in Microbiology 2, 449-454.
14. MINOR, P. D., MACADAM, A. J., STONE. D. M. & ALMOND, J. W. (1993). Genetic basis of attenuation of the Sabin oral poliovirus vaccines. Biologicals 21, 357-363.
15. PILIPENKO, E. V., MASLOVA, S. V., SINYAKOV, A. N. & AGOL, V. I. (1992 a). Towards identification of cis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: a proposal for the existence of tRNA-like terminal structures. Nucleic Acids Research 20, 1739-1745.
16. PILIPENKO, E. V., GMYL, A. P., MASLOVA, S. V., SVTTKIN, Y. V., SINYAKOV, A. N. & AGOL, V. I. (1992e). Prokaryotic-like cis-element in the cap-independent internal initiation of translation on picornavirus RNA. Cell 68, 119-131.
17. REN, R , Moss, E. G. & RACANIELLO, V. R. (1991). Identification of two determinants that attenuate vaccine-related type 2 poliovirus. Journal of Virology 65, 1377-1382.
18. REZAPKIN, G. V , CHUMAKOV, K. M., Lu, Z., RAN, Y., DRAGUNSKY, E. M. & LEVENBOOK, I. S. (1994). Microevolution of attenuated poliovirus in vitro and genetic stability of oral poliovirus vaccine. Virology 202, 370-378.
19. REZAFKIN, G. V., NORWOOD, L. P., TAFFS, R. E., DRAGUNSKY, E. M., LEVENBOOK, I. S. & CHUMAKOV, K. M. (1995). Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control. Virology 211, 377-384.
20. SABIN, A. B. (1955). Characteristics and genetic potentialities of experimentally produced and naturally occurring variants of poliomyelitis virus Annals of the New York Academy of Sciences 61, 924-938.
21. SABIN, A. B. (1957). Properties and behavior of orally administered attenuated poliovirus vaccine. Journal of the American Medical Association 164, 1216-1223.
22. SABIN, A. B. (1961). Reproductive capacity of polioviruses of diverse origin at various temperatures. In Perspectives in Virology, vol. 2, pp. 90-108. Edited by M. Pollard. Minneapolis: Burgess Publishing Company.
23. SKINNER, M. A., RACANIELLO, V. R., DUNN, G., COOPER, J., MINOR, P. D. & ALMOND, J. W. (1989). New model for the secondary structure of the 5′ non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important for neurovirulence. Journal of Molecular Biology 207, 379-392
24. TAFFS, R. E., CHUMAKOV, K. M., REZAPKIN, G. V., Lu, Z., DOUTHITT, M., DRAGUNSKY, E. M. & LEVENBOOK, I. S. (1995). Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown in different cell culture conditions. Virology 209. 366-373.
25. United States Code of Federal Regulations (1994). title 21. Washington DC: U. S. Government Printing Office.
26. WARD, C. D. & FLANEGAN, J. B (1992). Determination of the poliovirus RNA polymerase error frequency at eight sites in the viral genome. Journal of Virology 66, 3784-3793.
27. WARD, C. D., STOKES, M. A. M. & FLANEGAN, J. B. (1988). Direct measurment of the poliovirus RNA polymerase error frequency in vitro. Journal of Virology 62, 558-562.
28. WHO (1990). Requirements for poliovirus vaccine (oral). Technical Reports Series 800, 30-65. Geneva. World Health Organization.